Study to Demonstrate Cognitive Enhancing Effects of BF2.649
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the cognitive enhancing effect of BF2.649 and to evaluate the effect of BF2.649
on symptom severity in persons with schizophrenia or schizoaffective disorder.